Partner Content Partner Content Registration Opens for SMi’s 20th Annual Pain Therapeutics C... Registration Opens SMi’s Pain Therapeutics
Partner Content Partner Content 2 weeks until SMi’s 19th Annual Pain Therapeutics Conference... Only 2 weeks to SMi's 19th Annual Pain Therapeutics
Partner Content Partner Content Pain Therapeutics: Interviews AstraZeneca, Ensysce Bioscienc... Pain Therapeutics Exclusive Speaker Interviews Released
Partner Content Partner Content Interview released with Reckitt Benckiser, speaker at Pain T... Interview with Reckitt Benckiser - Pain Therapeutivcs
Partner Content Partner Content Chairs Centrexion Therapeutics & Metys Pharmaceuticals i... Co-Chairs invite to Pain Therapeutics Conference 2019
Events Partner Content SMi’s 19th Annual Pain Therapeutics Conference SMi's 19th Annual Pain Therapeutics Conference
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
